openPR Logo
Press release

Alpha Antitrypsin Deficiency Treatment Market is estimated to reach a valuation of US$2,908.1 mn by 2025

12-06-2017 12:32 PM CET | Industry, Real Estate & Construction

Press release from: Market Research Reports - MRRSE

MRRSE

MRRSE

Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Alpha 1 Antitrypsin Deficiency Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”.Alpha-1 Antitrypsin also referred as AAT, is a type of protein belongs to the class protease inhibitor. This protein is produced in the liver and is primarily functions to protect the lungs and liver from the harmful effects of other protein in the body. The AAT deficiency is genetic disorder that causes low and defective production of AAT proteins in liver which results in the accumulation of AAT in the liver and low amount of it in blood stream. The presence of AAT deficiency can be diagnosed using blood test, genetic tests and biopsy tests. Patients with severe AAT deficiency get affected by liver cirrhosis, chronic obstructive pulmonary diseases (COPD), and emphysema diseases. The diagnosis rate for alpha-1 antitrypsin deficiency across the globe is one of the crucial indicators of the alpha-1 antitrypsin deficiency treatment market. The AAT deficiency disease can be treated using different therapeutic methods such as augmentation therapy, bronchodilators, corticosteroids, oxygen therapy and other treatment methods.

Request For Free Sample Report @ https://www.mrrse.com/sample/3347

Global Alpha-1 Antitrypsin Deficiency Treatment Market: Trends and Opportunities

The worldwide increase in the incidences and prevalence of respiratory diseases is projected to be key driving factor for the global AAT deficiency market during forecast period. According to the Forum of International Respiratory Societies (FIRS), COPD affects more than 200 million people and is likely to be the fourth leading cause of death in the world by 2030, while asthma affects about 235 million people globally. AAT deficiency is most commonly observed in the North America and European countries which is likely to drive the market. The increasing awareness about AAT deficiency disorder in developed countries, technological development in in the production and purification of Alpha-1 Antitrypsin protein, and government initiatives for increasing blood and plasma derived products would boost the growth of global AAT deficiency treatment market. The AAT deficiency is common, but under diagnosed condition in most of countries. The slow diagnosis rates of AAT deficiency and high cost of treatment is likely to hamper growth of global AAT deficiency treatment market over forecast period. Alpha-1 antitrypsin deficiency (A1AD) mostly occurs in the Caucasian population of European descent, affecting approximately 100,000 Americans. However, most cases of A1AD are undetected, making alpha-1 antitrypsin deficiency a highly under-diagnosed disorder. Also the treatment of AAT deficiency may lead to development of several chronic side effects such as back/joint pain, chest pain, musculoskeletal pain, rhinorrhea, sinusitis, fever, nausea, or shortness of breath, peripheral edema, and urticarial. These side effects can sometimes force a patient to discontinue the therapy as alpha-1 antitrypsin is a natural enzyme inhibitor product.

Browse Full Report With TOC @ https://www.mrrse.com/alpha-1-antitrypsin-deficiency-treatment-market

Global Alpha-1 Antitrypsin Deficiency Treatment Market: Geographical Segmentation

Geographically, the global AAT deficiency treatment market has been segmented into five regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The North America dominated the global AAT deficiency treatment market in 2016 and is likely to lose its market share to Europe by the end of 2025.  Europe is projected to expand at highest CAGR during forecast period and is likely to gain its market share by the end of 2025. All the regions have been further segmented by countries, product type, by material and End-user segments. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the global AAT deficiency treatment market. The report also profiles major players in the market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Major companies competing in the non-vascular stents market, and profiled in the report include Grifols S.A., AstraZeneca, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, GlaxoSmithKline Plc., CSL Behring LLC, Shire plc, Pfizer Inc., LFB Biomedicaments S.A., Kamada Ltd.

The Global Alpha-1 Antitrypsin Deficiency Treatment Market has been segmented as follows:

Global Alpha-1 Antitrypsin Deficiency Treatment Market, by Treatment Type

Augmentation Therapy
Aralast
Prolastin
Zemaira/Respreeza
Glassia
Bronchodilator
Corticosteroids
Oxygen Therapy
Others
Global Alpha-1 Antitrypsin Deficiency Treatment Market, by Route of Administration

Parenteral
Inhalations
Oral
Global Alpha-1 Antitrypsin Deficiency Treatment Market, by End-User

Specialty Clinics
Hospitals
Pharmacies
Global Alpha-1 Antitrypsin Deficiency Treatment Market, by Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Make An Enquiry @ https://www.mrrse.com/enquiry/3347

Market Research Reports Search Engine(MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States
Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website : https://www.mrrse.com/
Read More Industry News At: https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Alpha Antitrypsin Deficiency Treatment Market is estimated to reach a valuation of US$2,908.1 mn by 2025 here

News-ID: 847892 • Views:

More Releases from Market Research Reports - MRRSE

Global Dairy Market Will Reach Value of US$ 9,570 Mn by 2022
Global Dairy Market Will Reach Value of US$ 9,570 Mn by 2022
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Dairy Alternatives Market: North America to dominate the market throughout the assessment period: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2022)”. Click here For Free Sample Report @ https://www.mrrse.com/sample/3558 The dairy alternatives market is growing at a steady pace the
Civilian Less Lethal and Self Defense Weapons Market Valued at US$82.16 Million by 2023
Civilian Less Lethal and Self Defense Weapons Market Valued at US$82.16 Million …
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Civilian Less Lethal and Self Defense Weapons Market - North America Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023”… Click here For Free Sample Report @ https://www.mrrse.com/sample/1764 Less lethal and self-defense weapons also known as “non-lethal” weapons are growing in demand
Market Research on Biosimulation Market To Worth US$ 1,750 Million in 2022
Market Research on Biosimulation Market To Worth US$ 1,750 Million in 2022
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Global Market Study on Biosimulation: North America to Dominate the Market in Terms of Revenue During the Forecast Period (2017 - 2022)”... Request Free Sample Report @ https://www.mrrse.com/sample/3772 Biosimulation is a technique in which computer programs are used for the simulation of biological processes.
Antiviral Medicine Market Anticipate it to Increase to US$82.9 bn by 2024
Antiviral Medicine Market Anticipate it to Increase to US$82.9 bn by 2024
Market Research Reports Search Engine (MRRSE) has been serving as an active source to cater intelligent research report to enlighten both readers and investors. This research study titled “Antiviral Medicine Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024” … Request Free Sample Report @ https://www.mrrse.com/sample/2551 With the significant increase in the incidence of viral infections, the global antiviral medicine market is witnessing a substantial rise in

All 5 Releases


More Releases for AAT

AAT Salt Recognized as the Best Salt Delivery Wisconsin 2025
AAT Salt is thrilled to announce its recognition as the best salt delivery service for Wisconsin homes and businesses [https://aatsalt.com/] by leading industry experts. Designed specifically for residents and businesses seeking hassle-free solutions, AAT Salt has emerged as the go-to provider of high-quality salt delivery and water treatment support across the region. With nearly a century of experience serving Southeastern Wisconsin (dating back to 1930) AAT Salt stands out in the
Anytime Anywhere Therapy (AAT): Breaking Barriers to Mental Health Care in Ontar …
Ontario, Canada -February 5, 2025 - Anytime Anywhere Therapy (AAT) is proud to serve individuals, couples, families, children (ages 6+), teenagers, and seniors across Ontario, offering inclusive, accessible, and fully online mental health services. Committed to eliminating barriers to mental health care, AAT provides round-the-clock support with licensed Canadian therapists who specialize in a wide range of therapeutic approaches and treatment areas. AAT's innovative platform not only benefits clients but also
Alpha 1-Antitrypsin (AAT) Replacement Therapy Market Global Research and Clinica …
Global Alpha 1-Antitrypsin (AAT) Replacement Therapy Market studies the latest industry trends, market development aspects, market gains, and industry scenario during the forecast period. The report provides the details related to fundamental overview, development status, latest advancements, market dominance and market dynamics. Buy Now This Report at: https://www.marketinsightsreports.com/report/purchase/071316596?mode=su?source=openpr&Mode=20 The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global
What's Driving the Wheelchair Stair Climber Market Growth? TopChair, Antano Grou …
UpMarketResearch.com includes new market research report Wheelchair Stair Climber Market to its huge collection of research reports. The Wheelchair Stair Climber Market report presents an all-inclusive approach to the Wheelchair Stair Climber Market growth along with a defined and methodical examination of the overall market. To start with, the report provides better insights of the competitive landscape of the global Wheelchair Stair Climber Market and also puts forth the several
Wheelchair Stair Climber Market 2017- TopChair, Antano Group, AAT, KSP ITALIA, B …
Wheelchair Stair Climber is an exercise machine on which helps wheel chair go upstairs or downstairs. These machines makes wheelchair climbing the stairs easily. These machines generally have two types, automatic and manual. Manual wheelchair need other people behind the wheel to control the climber while automatic climber can climb the stair by itself. Generally the automatic wheelchair climbers are powered by electricity. Request for sample(No Cost for sample) @ https://goo.gl/cpG0M9 Major
Global Alpha 1-Antitrypsin (AAT) Replacement Therapy Industry Analysis (2016-202 …
Researchmoz added Most up-to-date research on "Global Alpha 1-Antitrypsin (AAT) Replacement Therapy Market: Size, Trends and Forecast (2016-2020)" to its huge collection of research reports. The report titled Global Alpha 1-Antitrypsin (AAT) Replacement Therapy Market: Size, Trends and Forecast (2016-2020) provides an in-depth analysis of the global AAT Replacement Therapy market with detailed analysis of market sizing, growth and market share. The report provides market size by value and volume along